All In Biotech

Drug Trial Radar · NCT06527144

A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial of the Efficacy and Safety of Inhaled TQC3721 Suspension in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Last checked: Nov 20, 2026Latest source record: Apr 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 240 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

240

Actual

Start

Sep 14, 2024

Primary completion

Jan 16, 2025

Study completion Mar 6, 2025

Sponsor

Sponsor type
Industry
First posted
Jul 30, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the efficacy and safety of TQC3721 Suspension for Inhalation in patients with moderate to severe Chronic obstructive pulmonary disease (COPD)

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

  • 3mg TQC3721 Suspension for InhalationDrug

    TQC3721 suspension for inhalation is target inhibitor.

  • 6mg TQC3721 Suspension for InhalationDrug

    TQC3721 suspension for inhalation is target inhibitor.

  • Placebo TQC3721 suspension for inhalationDrug

    Placebo without active drug substance.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change of the maximum value of Forced Expiratory Volume in the first second (FEV1)Time frame: From baseline to four weeks after treatment

Locations

28 sites in 1 country. Site status is shown where the registry gives one.

  • Fu Yang People'S Hospital

    Fuyang, Anhui, China

  • ChongQing University Fuling Hospital

    Chongqing, Chongqing Municipality, China

  • The Second Affiliated Hospital of Xiamen Medical College

    Xiamen, Fujian, China

  • The First Hospital of Lanzhou University

    Lanzhou, Gansu, China

  • The First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, China

  • The People's Hospital of Guangxi Zhuang Autonomous Region

    Nanning, Guangxi, China

  • Zunyi Medical University Affiliated Hospital

    Zunyi, Guizhou, China

  • Cangzhou Hospital of Integrated Tcm-Wm·Hebei

    Cangzhou, Hebei, China

  • The Third Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China

  • Puyang Oilfield General Hospital

    Puyang, Henan, China

  • Shangqiu First People's Hospita

    Shangqiu, Henan, China

  • Chifeng Municipal Hospital

    Chifeng, Inner Mongolia, China

  • Wuxi Fifth People's Hospital

    Wuxi, Jiangsu, China

  • Yixing People'S Hospital

    Wuxi, Jiangsu, China

  • Northern Jiangsu People's Hospital

    Yangzhou, Jiangsu, China

  • Jiangxi Provincial People's Hospital

    Nanchang, Jiangxi, China

  • The First Hospital of Jilin University

    Changchun, Jilin, China

  • Siping Central People's Hospital

    Siping, Jilin, China

  • Genertec Liaoyou Gem Flower Hospital

    Panjin, Liaoning, China

  • Heze Municipal Hospital

    Heze, Shandong, China

  • Shanghai JiaoTong University of medicine Ruijin Hospital

    Shanghai, Shanghai Municipality, China

  • Shanxi Bethune Hospital

    Taiyuan, Shanxi, China

  • West China Hospital of Sichuan University

    Chengdu, Sichuan, China

  • Suining Central Hospital

    Suining, Sichuan, China

  • Tianjin Medical University General Hospital

    Tianjin, Tianjin Municipality, China

  • TianJin 4th Center Hospital

    Tianjin, Tianjin Municipality, China

  • The First Affiliated Hospital of Shihezi University

    Shihezi, Xinjiang, China

  • Wenzhou University Affiliated Second Hospital

    Wenzhou, Zhejiang, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.